Diagnostics & Research
The Diagnostics & Research industry has a total of 48 stocks, with a combined market cap of $674.16 billion, total revenue of $168.84 billion and a weighted average PE ratio of 38.81.
Market Cap
674.16B
Revenue
168.84B
Profits
17.37B
PE Ratio
38.81
Profit Margin
10.29%
Dividend Yield
0.24%
48 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 182.14B | 2.55% | 2,241,384 | 44.56B |
| 2 | DHR | Danaher Corporation | 134.43B | 0.05% | 4,195,569 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 45.40B | -1.43% | 361,538 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 32.27B | 1.95% | 2,076,858 | 7.07B |
| 5 | WAT | Waters Corporation | 29.62B | 0.04% | 671,019 | 3.17B |
| 6 | IQV | IQVIA Holdings Inc. | 28.19B | -0.52% | 1,515,128 | 16.31B |
| 7 | NTRA | Natera, Inc. | 27.17B | -2.78% | 787,282 | 2.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 25.70B | 2.05% | 147,806 | 4.03B |
| 9 | LH | Labcorp Holdings Inc. | 21.93B | 0.64% | 534,371 | 13.95B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.57B | 0.25% | 759,240 | 11.04B |
| 11 | EXAS | Exact Sciences Corporation | 20.03B | - | 21,561,523 | 3.25B |
| 12 | ILMN | Illumina, Inc. | 19.26B | 1.77% | 1,030,641 | 4.34B |
| 13 | MEDP | Medpace Holdings, Inc. | 13.08B | 0.83% | 197,713 | 2.53B |
| 14 | GH | Guardant Health, Inc. | 10.96B | -1.61% | 1,746,201 | 982.02M |
| 15 | RVTY | Revvity, Inc. | 9.78B | 0.34% | 621,829 | 2.86B |
| 16 | QGEN | Qiagen N.V. | 8.63B | 0.73% | 1,863,284 | 2.09B |
| 17 | CRL | Charles River Laboratories International, Inc. | 7.84B | 0.75% | 598,230 | 4.02B |
| 18 | ICLR | ICON Public Limited Company | 7.73B | 0.93% | 778,745 | 8.10B |
| 19 | RDNT | RadNet, Inc. | 4.65B | -3.03% | 830,703 | 2.04B |
| 20 | SHC | Sotera Health Company | 3.93B | -0.32% | 2,753,167 | 1.16B |
| 21 | BLLN | BillionToOne, Inc. | 3.41B | -6.92% | 224,335 | 305.11M |
| 22 | TWST | Twist Bioscience Corporation | 2.91B | 6.72% | 1,451,481 | 391.56M |
| 23 | VCYT | Veracyte, Inc. | 2.62B | -1.79% | 949,699 | 517.15M |
| 24 | WGS | GeneDx Holdings Corp. | 2.01B | -4.81% | 385,914 | 427.54M |
| 25 | GRAL | GRAIL, Inc. | 2.00B | -0.98% | 462,581 | 147.17M |
| 26 | NEO | NeoGenomics, Inc. | 1.02B | -2.96% | 1,176,449 | 727.33M |
| 27 | CDNA | CareDx, Inc. | 913.70M | 1.59% | 641,999 | 379.81M |
| 28 | OPK | OPKO Health, Inc. | 867.50M | -1.74% | 3,527,500 | 606.88M |
| 29 | PSNL | Personalis, Inc. | 814.04M | 2.23% | 1,216,451 | 69.65M |
| 30 | CSTL | Castle Biosciences, Inc. | 753.69M | -1.55% | 230,860 | 344.23M |
| 31 | BNR | Burning Rock Biotech Limited | 522.07M | 6.68% | 34,396 | 77.14M |
| 32 | FLGT | Fulgent Genetics, Inc. | 510.31M | 0.06% | 754,139 | 322.67M |
| 33 | MYGN | Myriad Genetics, Inc. | 431.07M | -1.07% | 1,774,055 | 824.50M |
| 34 | PRE | Prenetics Global Limited | 372.75M | 3.22% | 343,711 | 92.39M |
| 35 | BDSX | Biodesix, Inc. | 153.20M | 5.79% | 81,836 | 88.50M |
| 36 | MDXH | MDxHealth SA | 143.54M | -9.09% | 989,061 | 107.88M |
| 37 | FONR | FONAR Corporation | 120.69M | 0.38% | 59,561 | 106.03M |
| 38 | IMDX | Insight Molecular Diagnostics Inc. | 114.66M | - | 318,647 | 4.40M |
| 39 | XGN | Exagen Inc. | 65.91M | -3.86% | 339,239 | 66.58M |
| 40 | PRPO | Precipio, Inc. | 46.60M | -1.23% | 7,724 | 22.80M |
| 41 | BIAF | bioAffinity Technologies, Inc. | 17.81M | -16.28% | 4,671,109 | 6.16M |
| 42 | MBAI | Check-Cap Ltd. | 12.10M | -2.92% | 23,400 | - |
| 43 | NOTV | Inotiv, Inc. | 10.84M | -3.55% | 248,093 | 514.03M |
| 44 | XWEL | XWELL, Inc. | 7.79M | -2.17% | 156,805 | 29.52M |
| 45 | QUCY | Mainz Biomed N.V. | 6.24M | 3.90% | 199,595 | 659.94K |
| 46 | ADVB | Advanced Biomed Inc. | 4.37M | -3.35% | 4,384 | - |
| 47 | NDRA | ENDRA Life Sciences Inc. | 4.04M | -0.57% | 5,175 | - |
| 48 | ISPC | iSpecimen Inc. | 1.49M | -15.37% | 3,672,544 | 3.35M |